Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

Logo
HSCS US​

HeartSciences Inc.(HSCS US)

$3.14-0.030.95%Ext:$3.25+0.113.50%(Market Closed · 00:00:02 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

HeartSciences Inc. — Company Profile

HeartSciences Inc. is a medical technology company dedicated to augmenting the clinical utility of electrocardiograms (ECGs) by integrating artificial intelligence (AI). The firm develops AI-enhanced ECG (AI-ECG) solutions, including an algorithm specifically designed to detect impaired cardiac relaxation or other forms of cardiac dysfunction, whether caused by heart disease or the natural aging process. Among its offerings is the MyoVista wavECG device, a 12-lead resting ECG that provides comprehensive diagnostic information concerning cardiac function alongside conventional ECG data in a single examination. Furthermore, the company offers MyoVista Insights, a cloud-based platform capable of hosting its AI-ECG algorithms across various ECG hardware systems. Established in 2007, HeartSciences Inc. operates from its headquarters in Southlake, Texas. The company was formerly named Heart Test Laboratories, Inc. until its rebranding to HeartSciences Inc. in October 2024.

Sector
Materials
Industry
Paper & Forest Products
Exchange
UQ
CEO
Andrew Simpson
Headquarters
Southlake, TX, US
IPO Date
Jun 16, 2022
Employees
14
Website
heartsciences.com

Key Metrics

Price
$4.30
Market Cap
$9.29M
Revenue (TTM)
$2.10M
Net Income (TTM)
$-3172344000.00
EPS (TTM)
-0.86
P/E (TTM)
-1.09
P/B (TTM)
-0.00
Dividend Yield
0.00%
ROE (TTM)
156.03%
ROA (TTM)
-84.89%
Operating Margin
-1399.57%
Beta
0.15

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

HeartSciences Inc. is a medical technology company dedicated to augmenting the clinical utility of electrocardiograms (ECGs) by integrating artificial intelligence (AI). The firm develops AI-enhanced ECG (AI-ECG) solutions, including an algorithm specifically designed to detect impaired cardiac relaxation or other forms of cardiac dysfunction, whether caused by heart disease or the natural aging process. Among its offerings is the MyoVista wavECG device, a 12-lead resting ECG that provides comprehensive diagnostic information concerning cardiac function alongside conventional ECG data in a single examination. Furthermore, the company offers MyoVista Insights, a cloud-based platform capable of hosting its AI-ECG algorithms across various ECG hardware systems. Established in 2007, HeartSciences Inc. operates from its headquarters in Southlake, Texas. The company was formerly named Heart Test Laboratories, Inc. until its rebranding to HeartSciences Inc. in October 2024.

Website
heartsciences.com
Location
Southlake, TX, US
Phone682 237 7781
Employees14
CEOAndrew Simpson
Sector
Materials
Industry
Paper & Forest Products
IPO DateJun 16, 2022

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.

Latest Documents

SEC Filings(326)

Expand
  • SC 13D/AHeartSciences Inc.23 Oct
  • DEFA14ADEFINITIVE ADDITIONAL MATERIALS21 Oct
  • DEFA14ADEFINITIVE ADDITIONAL MATERIALS19 Oct
  • DEFA14ADEFINITIVE ADDITIONAL MATERIALS19 Oct
  • DEFM14APROXY STATEMENT19 Oct
  • DEFA14ADEFINITIVE ADDITIONAL MATERIALS15 Oct
  • 424B5PROSPECTUS SUPPLEMENT9 Oct
  • DEFA14ACURRENT REPORT6 Oct
  • 8-KPRESS RELEASE, DATED OCTOBER 6, 20266 Oct
  • DEFA14ADEFINITIVE ADDITIONAL MATERIALS6 Oct
  • PRER14APROXY SATEMENT5 Oct
  • DEFA14ACURRENT REPORT2 Oct
  • 8-KEntry into a Material Definitive Agreement2 Oct
  • DEFA14ADEFINITIVE ADDITIONAL MATERIALS30 Sep
  • S-3REGISTRATION STATEMENT25 Sep
  • DEFA14ADEFINITIVE ADDITIONAL MATERIALS24 Sep
  • DEFA14ADEFINITIVE ADDITIONAL MATERIALS21 Sep
  • DEFA14ADEFINITIVE ADDITIONAL MATERIALS18 Sep
  • PRER14APROXY STATEMENT17 Sep
  • DEFA14ADEFINITIVE ADDITIONAL MATERIALS17 Sep

News

  • Is HeartSciences Inc. (HSCS) Stock Outpacing Its Medical Peers This Year?22 Oct
  • HeartSciences Files Definitive Proxy Statement for Proposed Business Combination with Fortitude Mining21 Oct
  • HeartSciences Receives FDA 510(k) Clearance for its MyoVista® wavECGTM Device6 Oct
  • Fortitude Appoints Kimberly Pittman as Chief Legal Officer29 Sep
  • HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update15 Sep
  • HeartSciences Inc. (HSCS) Reports Q1 Loss, Misses Revenue Estimates14 Sep
  • Fortitude Invests $1.0 Million in HeartSciences at a 22% Premium with No Adjustment to the Merger Consideration19 Aug
  • Fortitude Purchases 9,000 Bitmain Antminer Z15 Pro Units, Deepening Commitment to the Zcash Ecosystem30 Jul
  • HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results29 Jul

Mentions in Filings

  • … saction. From June 2021 to September 2022, Mr. Wells served as Chief Financial Officer of GHS Investments, LLC, a private equity fund. Since December 2022, Mr. Wells has served as a member of the Board of Directors of <strong>HeartSciences</strong>, Inc. (Nasdaq: HSCS). Mr. Wells has a bachelor's degree in finance and entrepreneurship from Seattle Pacific University and a master of business administration from Pepperdine Graziadio Business School. There are no f …
    Global Innovative Platforms Inc.HeartSciences Inc.·8-K - Entry into a Material Definitive Agreement·Q1 27·6 Oct
  • … nvoy Medical, Inc. (Nasdaq: COCH). From June 2021 to September 2022, he served as Chief Financial Officer of GHS Investments, LLC, a private equity fund. Since December 2022, he has served on the Board of Directors of <strong>HeartSciences</strong>, Inc. (Nasdaq: HSCS). Mr. Wells holds a bachelor's degree in finance and entrepreneurship from Seattle Pacific University and a Master of Business Administration from Pepperdine Graziadio Business School. Mr. Wells pr …
    Global Innovative Platforms Inc.HeartSciences Inc.·EX-99.1 - 8-K - Entry into a Material Definitive Agreement·Q1 27·6 Oct
  • … ny’s deSPAC transaction. From June 2021 to September 2022, Mr. Wells served as Chief Financial Officer of GHS Investments, LLC, a private equity fund. Since December 2022, Mr. Wells has served as a member of the Board of Directors of <strong>HeartSciences</strong>, Inc. (Nasdaq: HSCS). Mr. Wells has a bachelor’s degree in finance and entrepreneurship from Seattle Pacific University and a master of business administration from Pepperdine Graziadio Business School.
    Fusemachines Inc.HeartSciences Inc.·8-K - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers·Q3 26·4 Sep
  • … es ZEC and operates mining infrastructure on the Zcash Network. Fortitude is a vertically-integrated digital asset mining platform focused on Zcash. While Fortitude has announced a proposed business combination with <strong>HeartSciences Inc.</strong>, it is expected that upon the consummation of such business combination, DCG will maintain control of the combined company. In addition, Foundry Digital LLC (“Foundry”), a subsidiary of DCG and affiliate of the Spon …
    Zcash ETFHeartSciences Inc.·424B3 - Prospectus filing (Rule 424(b)(3))·Q3 26·25 Aug
  • … es ZEC and operates mining infrastructure on the Zcash Network. Fortitude is a vertically-integrated digital asset mining platform focused on Zcash. While Fortitude has announced a proposed business combination with <strong>HeartSciences Inc.</strong>, it is expected that upon the consummation of such business combination, DCG will maintain control of the combined company. In addition, Foundry Digital LLC (“Foundry”), a subsidiary of DCG and affiliate of the Spon …
    Zcash ETFHeartSciences Inc.·424B3 - Prospectus filing (Rule 424(b)(3))·Q3 26·24 Aug
  • … es ZEC and operates mining infrastructure on the Zcash Network. Fortitude is a vertically-integrated digital asset mining platform focused on Zcash. While Fortitude has announced a proposed business combination with <strong>HeartSciences Inc.</strong>, it is expected that upon the consummation of such business combination, DCG will maintain control of the combined company. In addition, Foundry Digital LLC (“Foundry”), a subsidiary of DCG and affiliate of the Spon …
    Grayscale Zcash Trust (ZEC)HeartSciences Inc.·S-3/A - Registration statement (primary offering, amendment)·Q3 26·21 Aug

Key Stats

Trading

Px/Chg 1D$4.30 / +10.54%
Avg Volume1.58M
Beta0.15
Mkt Cap9.29M
FD Mkt Cap6.56M

Float

Shrs Out/Float2.16M / 1.96M
Short Float0.06%
Days to Cover1.00
Stock Repurchased$0.00

Current Valuation

EV3.98B
EV/EBITDA-520.75
EV/Sales459,601.21
P/B-0.00
P/S1,071.16
FCF Yield-14202.89%
ROE156.03%
ROA-84.89%
Current Ratio0.14

Estimates

P/E-1.09
Est P/EN/A
Est EPSN/A
Est PEGN/A

Valuation

Metric5Yr AvgSep '23Sep '24Sep '25Sep '26Oct '26
PRICE-BASED RATIOS
Price / Earnings-1.33-1.04-0.15-1.76-3.69-0.00
Price / Sales437.331,281.3453.45847.410.004.42
Price / Book Value9.9028.620.1417.972.76-0.00
Price / Free Cash Flow-0.72-1.14-0.16-2.31-0.00-0.01
ENTERPRISE VALUE METRICS
Enterprise Value121.36.5-3.85.6-3,385.83,984.3
Enterprise Value / Sales847.721,263.05-203.061,281.320.001,897.28
Enterprise Value / EBITDA357.25-1.070.61-2.961,791.02-1.36
Enterprise Value / EBIT351.34-1.060.60-2.911,760.070.00

Financials

Full Financials
Millions USD5Yr CAGR (%)Apr '21Apr '22Apr '23Apr '24Apr '25
INCOME STATEMENT
Revenue-35.8%0.00.00.00.00.0
Gross Income61%-0.0-0.0-0.0-0.1-0.1
EBITDA37.4%-2.3-4.4-6.1-6.2-8.1
EBIT37.4%-2.3-4.5-6.1-6.3-8.3
Net Income37.5%-2.5-4.8-6.4-6.6-8.8
EPS (Diluted)-41.2%-77.89-137.94-6,173.88-18.74-9.34
BALANCE SHEET
Cash & ST Inv11%0.70.91.75.81.1
Total Assets21.7%1.92.13.39.54.2
Total Liabilities1.2%3.88.13.12.24.0
Total Shareholder Equity—-1.9-6.10.27.30.2
CASH FLOW
Net Operating Cash Flow31.9%-2.5-3.6-5.8-6.1-7.4
Cap Ex155.2%-0.0-0.0-0.0-0.1-0.0
Free Cash Flow32%-2.5-3.6-5.8-6.2-7.4

Enterprise Value Bridge

Millions USD23 Oct '26
Price (As of 23 Oct '26)3.11
Basic Shares2.16
Market Cap6.7
Diluted Shares3.67
Fully Diluted Shares Outstanding3.67
Fully Diluted Market Cap11.4
+Consolidated Debt4,004.5
−In-the-Money Convertible Debt—
+Capital Leases-
+Operating Leases—
−Cash & Equivalents-29.9
−Short-term Investments-
+Total Preferred0.4
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value3,981.7

Related companies

Lion Group Holding Ltd

LGHL US

American Express Company

AXP US

Nu Holdings Ltd.

NU US

Strategy Inc

MSTR US

Guotai Junan Securities Co., Ltd.

GUOSF US

CITIC Securities Company Limited

CIIHY US

Coinbase Global, Inc.

COIN US

Affirm Holdings, Inc.

AFRM US

Synchrony Financial

SYF US

GF Securities Co., Ltd.

000776 CS

CSC Financial Co., Ltd.

601066 CG

China Merchants Securities Co., Ltd.

600999 CG